Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1 [Letter]
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s491658 ↗Kurz gefasst
Leserbrief in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Vidak Raičević. Beteiligte Einrichtung: Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia. Hauptthemen laut MEDLINE: Signal Transduction, LIM Domain Proteins, Mouth Neoplasms, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Suppresses the Progression of Human Oral
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Zitieren
APA
Raičević, V. (2024). Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1 [Letter]. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s491658
Vancouver
Raičević V. Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1 [Letter]. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s491658
BibTeX
@article{Raievi2024,
author = {Raičević, Vidak},
title = {Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1 [Letter]},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s491658}
}
EUVIMED